HOME >> MEDICINE >> NEWS
ILEX Oncology & LeukoSite report results from pivotal Phase II CAMPATH (R) trial; Results suggest new hope for refractory chronic lymphocytic leukemia

der to reduce the incidence and severity of infusion-related adverse events. Patients also received prophylactic anti-infective treatment to reduce the risk of opportunistic infections. The primary endpoint for this trial was overall response rate (complete and partial response), and the study objective was to demonstrate a major response rate of at least 20 percent. Response rate was assessed by an independent review panel in accordance with the National Cancer Institute's guidelines for the diagnosis and treatment of CLL.

Of 93 evaluable patients, 31 demonstrated an objective response to treatment, for an overall response rate of 33%. Two of these responses were complete (2%) and 29 were partial responses (31%). Another 55 (59%) patients had disease stabilization. Median survival time has not yet been reached at about 10 months after the last patient was enrolled.

The safety profile of CAMPATH was consistent with that seen in previous studies and was judged by the investigators to be acceptable in this group of endstage CLL patients.

Adverse effects associated with CAMPATH in this study of 93 patients were mostly mild to moderate infusion-related symptoms. Severe (grade 3 and 4) infusion-related symptoms included: fever (13%), rigors (11%), dyspnea (6%), and hypotension (1%). During the study patients developed severe (grade 3 and 4) thrombocytopenia (low platelet count, 51%) or neutropenia (low white blood cell count, 61%) that usually improved within two months post-therapy. Some patients entering the study with severe (grade 3 and 4) thrombocytopenia and neutropenia improved to grade 2 or better within two months post-therapy: thrombocytopenia -- 7 of 19 (37%) patients improved,neutropenia -- 11 of 17 (65%) patients improved.

No unexpected serious adverse events were reported. The incidence of serious infections was reported to be 20% on this trial. It should be noted that infection is a common complication and cause of death
'"/>

Contact: Deborah Sibley, ILEX Oncology
210-949-8287
Porter Novelli
12-Jun-1999


Page: 1 2 3 4 5

Related medicine news :

1. The 23rd Congress of the European Society for Therapeutic Radiology and Oncology (ESTRO)
2. Oncology Nursing Society honors Fox Chase Cancer Center nurse with Radiation Therapy Nursing Award
3. The Lancet Oncology (TLO)
4. The Lancet Oncology press release
5. The Lancet Oncology (TLO) and the Lancet Infectious Diseases (TLID)
6. The Lancet Oncology (TLO) June 2002
7. The Lancet Oncology (TLO) and The Lancet Infectious Diseases (TLID)
8. The Lancet Oncology and The Lancet Infectious Diseases
9. V. Craig Jordan Will Present Results Of Raloxifene Breast Cancer Study At American Society For Clinical Oncology Meeting
10. First UK cases of previously rare disease reported in gay men
11. Health care report cards may increase racial/ethnic disparities in bypass operations

Post Your Comments:
(Date:5/22/2015)... 22, 2015 Bryce Henson, local fitness ... Body Boot Camp, recently accepted his program’s 100th client. ... the launch of his location evidences the powerful impact ... , Fit Body Boot Camp is the nation’s most ... with hundreds of locations across North America, Europe and ...
(Date:5/22/2015)... Janesville, WI (PRWEB) May 22, 2015 ... an honor to be recognized for providing the highest ... the foundation of health care decision-making,” said Javon R. ... award demonstrates the commitment of our employee/partners to care ... our patients.” , Hospitals do not apply for this ...
(Date:5/21/2015)... May 21, 2015 Her popular Love Seminar ... Hilton Hotel in San Gabriel on Saturday, May 23rd. ... again from men and women who are unhappy in their ... partner." , "Many singles think that their biggest problem is ... would go from one relationship to another trying to find ...
(Date:5/21/2015)... Ticket Down is a reliable source for authentic tickets to ... on Friday, July 3rd at LP Field in Nashville, TN. ... international soccer. The number of chances to watch some of the ... at a large clip. Over the past several years, many of ... play in front of the American people. The match between the ...
(Date:5/21/2015)... York, New York (PRWEB) May 21, 2015 ... The Atmananda Yoga Studio and Sequence, is excited ... Atmananda Yoga Mat™, which was previously available for use ... Atmananda Yoga Mat™ unique is that it's mathematically ... prevent serious joint injuries and muscle strains, commonly ...
Breaking Medicine News(10 mins):Health News:Healthy Living Brought to Anaheim— New Fitness Boot Camp Acquires 100 Clients 2Health News:Mercy Hospital and Trauma Center Receives Women’s Choice Award for Emergency Care - Mercy Health System Javon Bea 2Health News:Bestselling Author Sheds Light on Why Modern Dating is Hurting People's Chances of Finding a Lasting Relationship 2Health News:USA vs. Guatemala Tickets: Ticket Down Slashes United States Men's Soccer Team (USMNT) vs. Guatemala Tickets at LP Field in Nashville on 7/3/15 2Health News:NY's Atmananda Yoga Studio Launches Its Patented "Alignment" Yoga Mat for Public Sale 2
(Date:5/21/2015)... 2015 Northwest Biotherapeutics, Inc. (NASDAQ: NWBO ... immune therapies for cancer, announced today that Dr. ... Company, will be making a presentation at the New ... Immunotherapy at 11:40 a.m. on May 21, 2015, at the ... Dr. Bosch,s presentation is entitled "DCVax-Direct, ...
(Date:5/21/2015)... and SEATTLE , May 21, ... the development of robotics, sensors and medical devices, announced ... the company,s Chief Financial Officer and head of Corporate ... in corporate development, business development and finance roles, including ... and Pendrell Corporation.  Mr. Woo will be located in ...
(Date:5/21/2015)... N.Y. , May 21, 2015 Hope ... groundbreaking national alliance with USA ... cards. The new nationwide initiative benefiting Hope For Heroes ... nation,s disabled military veterans, police, firemen, and EMS professionals, ... "Hope For Heroes is thrilled to welcome ...
Breaking Medicine Technology:NW Bio To Present At New York Academy Of Sciences' Conference On Emerging Approaches To Immunotherapy 2NW Bio To Present At New York Academy Of Sciences' Conference On Emerging Approaches To Immunotherapy 3Sarcos Corp. Announces Preston Woo as CFO and Head of Corporate Development 2Hope For Heroes Joins Forces with USA Medical Card 2
Cached News: